PepGen (PEPG) Stock Price, Quote, News & History | Benzinga

PepGen Inc (PEPG) Stock Price, Quote, News & History

PEPGNASDAQ

Trade with Public

Trade with Public

$2.91

-0.13-4.28%

At close: Aug 18, 5:00 PM EST

$2.90

-0.01-0.34%

After Hours: 4:21 PM EST

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

$3.03

Close

$2.91

Volume / Avg.

677.25K / 923.66K

Day Range

$2.90 - $3.09

52 Wk Range

1.13 - 7.80

Market Cap

$200.85M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

68

Short Interest

8.37%

Days to Cover

6.1

Recent PepGen Inc. News

Top 3 Health Care Stocks Which Could Blast Off This Quarter

Undervalued companies in health care sector with low RSI values present buying opportunity: PepGen Inc (PEPG), KALA BIO Inc (KALA), Viridian Therapeutics Inc (VRDN)

Avi Kapoor

Scholar Rock To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Wednesday

Top Wall Street analysts changed their outlook on top names. For a complete view of all rating changes, see analyst ratings page.

Avi Kapoor

Gold Gains Over 1%; FactSet Research Raises FY2026 Outlook

US stocks rise on Tuesday, with NASDAQ up 2% and Dow up 1.37%. Communication services shares gain 2.2%, while utilities fall 0.7%. FactSet reports upbeat Q2 results and raises outlook.

Avi Kapoor

Dow Jumps 400 Points; TD Synnex Posts Upbeat Earnings

US stocks higher, Dow up 0.90%, Nasdaq up 1.61%. Communication services gained 1.8%, utilities fell 0.6%. TD Synnex beats earnings estimates.

Avi Kapoor

Why Is PepGen Stock Sinking Tuesday?

PepGen stock drops after Phase 2 low-dose data show limited splicing correction; higher-dose cohorts and FDA hold remain key focus areas.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-69.34M

Investing Cash Flow (TTM)

-52.32M

Financing Cash Flow (TTM)

109.33M

Free Cash Flow (TTM)

-69.46M

Capital Expenditure (TTM)

-126.00K

Net Change in Cash (TTM)

-12.32M

Analyst Trends and Forecast

1

Feb

1

Mar

1

Apr

1

May

1

Jun

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.7

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$109.40M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

-

PB Ratio (TTM)

1.76

Earnings Yield % (TTM)

-32.89%

Earnings Yield % (FWD)

-36.02%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$1.73

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$22.76M

Debt to Equity

0.13

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

$3.03

Close

$2.91

Volume / Avg.

677.25K / 923.66K

Day Range

$2.90 - $3.09

52 Wk Range

1.13 - 7.80

Market Cap

$200.85M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

68

Short Interest

8.37%

Days to Cover

6.1

About

Sector

Health Care

Industry

Biotechnology

PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleo...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy PepGen (PEPG) stock?

A

You can purchase shares of PepGen (NASDAQ:PEPG) through any online brokerage.

View our list of the best stock brokerages

Q

Who are PepGen (PEPG) competitors?

A

Other companies in PepGen’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).

Q

What is the forecast, or price target, for PepGen (PEPG) stock?

A

PepGen has a consensus price target of $10.00.

Q

What is the current price for PepGen (PEPG)?

A

The stock price for PepGen (NASDAQ: PEPG) is $2.9 last updated August 18, 2026 at 4:21 PM EDT.

Q

Does PepGen (PEPG) pay a dividend?

A

There are no upcoming dividends for PepGen.

Q

When is PepGen (NASDAQ:PEPG) reporting earnings?

A

PepGen does not have any upcoming earnings scheduled.

Q

Is PepGen (PEPG) going to split?

A

There is no upcoming split for PepGen.

Q

What sector and industry does PepGen (PEPG) operate in?

A

PepGen is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.